Tobacco Use Disorder: Clinical Trials

1,025 trials for Tobacco Use Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

737 completed, 84 recruiting, 61 unknown, 50 terminated. 493 Not applicable, 204 Phase 2, 96 Phase 1, 95 Phase 4, 77 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable493Completed 333, Recruiting 51, Unknown 38, Not yet recruiting 18, Withdrawn 17, Active not recruiting 13, Terminated 13, Enrolling by invitation 7, Suspended 3
Phase 2204Completed 154, Terminated 17, Recruiting 12, Withdrawn 9, Unknown 8, Active not recruiting 2, Not yet recruiting 2
Phase 196Completed 75, Withdrawn 8, Recruiting 5, Terminated 5, Unknown 3
Phase 495Completed 69, Recruiting 9, Terminated 7, Unknown 4, Withdrawn 4, Active not recruiting 1, Not yet recruiting 1
Phase 377Completed 60, Terminated 6, Unknown 5, Recruiting 4, Active not recruiting 2
Early Phase 127Completed 22, Recruiting 3, Terminated 1, Unknown 1

Follow Tobacco Use Disorder: new trials by email Literature Review of Tobacco Use Disorder trials Research Report on Tobacco Use Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV
Phase 4Not yet recruitingYale University7942027-09-302026-09-23
Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness
Cognitive Behavioral Therapy for Smoking Cessation, Nicotine Replacement Therapy, Bupropion - Tobacco Use Disorder
Not applicableNot yet recruitingVA Office of Research and Development1202027-03-012026-07-20
Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder
Deep TMS System With H4 Coil - Opioid Use Disorder, Tobacco Use Disorder
Not applicableNot yet recruitingPayel Roy122027-01-012026-08-27
Effects of Very Low Nicotine Content Cigarettes Among Adults Who Smoke Daily in South Korea
SPECTRUM cigarettes - Cigarette Smoking, Nicotine Dependence
Not applicableNot yet recruitingSung-il Cho3002027-01-012026-08-10
Effects of Psilocybin on Craving in Nicotine Dependence
Psilocybin (drug) - Nicotine Dependence
Phase 2Not yet recruitingUniversity of British Columbia32027-01-012026-10-01
Chatbot for Online Support Groups to Treat Tobacco Addiction
online quit-smoking support group with intelligent chatbot, online quit-smoking support group with unintelligent bot - Tobacco Dependence, Tobacco Use Disorder
Not applicableNot yet recruitingUniversity of California, Irvine1202026-12-012026-05-22
Quit With Sense: Using Mindful Smoking and Wearable Device for Smoking Cessation
Mindful Smoking and Sensor-Band Intervention, Smoking Cessation Information - Smoking Cessation, Cigarette Smoking
Not applicableNot yet recruitingUniversity of Minnesota302026-11-102026-10-13
Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders
Major Depressive Disorder, Bipolar Disorder
Not yet recruitingAssiut University2402026-11-012026-11-02
Developing an E-Cigarette Cessation Intervention for Hispanic/Latina(o) Youth in Florida: The BReATHE Study
E-cigarette Cessation Manual - Vaping Teens, Vaping Behaviors
Not applicableRecruitingFlorida International University1202026-10-262026-10-28
TORCH - Transdiagnostic Observation of Risk Factors, Craving and Health Behaviours in Psychiatric Patients
person-centred interventions - Psychiatric Disorders
Not yet recruitingJacobs University Bremen gGmbH2502026-10-012026-09-28
THCV Treatment for Smokers
Δ9-Tetrahydrocannabivarin (oral gummy), Matched Placebo (oral gummy) - Tobacco Use Disorder, Smoking Cessation
Phase 2Not yet recruitingUniversity of California, Los Angeles322026-10-012026-08-04
Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation
Quitoxil®, Nicotine Replacement Therapies - Tobacco Use Disorder
Not applicableNot yet recruitingKLAVA Innovation6062026-10-012026-07-24
Evaluation of Community Health Worker Support to Help People With Serious Mental Illness to Quit Smoking
Integrated CHW Support intervention, Enhanced usual care (EUC) - Nicotine Dependance, Serious Mental Illness
Not applicableNot yet recruitingMassachusetts General Hospital9372026-10-012026-08-27
Prevalence and Association of Dysfunctional Breathing With Nicotine Dependence and Physical Activity Among Young Smokers
Observational evaluation. - Dysfunctional Breathing, Physical Activity
Not yet recruitingIstinye University4202026-09-302026-09-28
§SMOKE Nicotine and Tobacco Youth Cohort
Tobacco Use Behavior, Nicotine Dependence Tobacco Product
RecruitingUniversity of Southern Denmark100002026-09-232026-11-02
LaunchPad: Supporting Healthy Decisions and Preventing Drug Use After High School
Introduction, Norms re: Protective Behavior Strategies (PBS), Life Skills - Substance-related Disorders, Alcohol-Related Disorders
Not applicableNot yet recruitingPrevention Strategies, LLC50002026-09-012026-06-25
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT) - Tobacco Use Cessation, Tobacco Use Disorder
Not applicableNot yet recruitingUniversity of Virginia1202026-09-012026-07-10
AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation
AI-enhanced smartphone app, AI-enhanced smartphone app, but with delayed access - Nicotine Dependence, Cigarettes
Not applicableNot yet recruitingState University of New York at Buffalo1002026-08-242026-08-06
Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability
Biospecimen Collection, Questionnaire Administration, Cigarette Purchase Task - Cigarette Addiction, Tobacco Use Disorder
Not applicableRecruitingOhio State University Comprehensive Cancer Center482026-08-182026-10-14
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Motivation-Phase Varenicline, Motivation-Phase Nicotine Mini-Lozenge, Cessation-Phase Combination Nicotine Replacement Therapy (NRT) - Veterans, Tobacco Use Disorder
Phase 4RecruitingVA Office of Research and Development4002026-08-172026-08-31

Showing 20 of 1025. Sign in to see all of them.

Narrower conditions

Smoking Cessation (318)  ·  Smoking (246)  ·  Cigarette Smoking (89)  ·  Vaping (78)  ·  Tobacco Use (69)  ·  Tobacco Use Cessation (66)  ·  Substance-Related Disorders (52)  ·  Tobacco Smoking (51)  ·  Alcoholism (35)  ·  Behavior, Addictive (33)  ·  Schizophrenia (33)  ·  Lung Neoplasms (28)  ·  Mental Disorders (19)  ·  Carcinoma, Non-Small-Cell Lung (18)

Broader conditions

Chemically-Induced Disorders (1025)  ·  Mental Disorders (1006)  ·  Substance-Related Disorders (973)  ·  Behavior (641)  ·  Health Behavior (353)  ·  Smoking (148)  ·  Tobacco Use (100)  ·  Tobacco Smoking (75)  ·  Pathological Conditions, Signs and Symptoms (44)  ·  Respiratory Tract Diseases (43)  ·  Neoplasms (41)  ·  Neoplasms by Site (39)  ·  Lung Diseases (38)  ·  Alcohol-Related Disorders (34)  ·  Compulsive Behavior (33)

Interventions

Tobacco Use Cessation Devices (124)  ·  Nicotine (104)  ·  Varenicline (96)  ·  Bupropion (54)  ·  Nicotine Replacement Therapy (46)  ·  Nicotine Chewing Gum (33)  ·  Electronic Nicotine Delivery Systems (26)  ·  Counseling (25)  ·  Behavior Therapy (23)  ·  Sugars (19)  ·  Cognitive Behavioral Therapy (16)  ·  Transcranial Magnetic Stimulation (15)  ·  Tobacco Products (14)  ·  Exercise (12)  ·  Progesterone (10)

Sponsors

National Institute on Drug Abuse (NIDA) (68)  ·  Yale University (58)  ·  University of Pennsylvania (39)  ·  University of California, San Francisco (32)  ·  University of Minnesota (30)  ·  Centre for Addiction and Mental Health (29)  ·  Medical University of South Carolina (28)  ·  University of Wisconsin, Madison (27)  ·  Duke University (26)  ·  Mayo Clinic (24)  ·  Massachusetts General Hospital (22)  ·  McNeil AB (18)  ·  University of Vermont (18)  ·  VA Office of Research and Development (17)  ·  Brown University (15)

Countries

United States (798)  ·  Canada (43)  ·  Sweden (18)  ·  France (17)  ·  Germany (14)  ·  Turkey (Türkiye) (12)  ·  China (8)  ·  Spain (8)  ·  United Kingdom (7)  ·  Brazil (6)  ·  Czechia (4)  ·  Denmark (4)  ·  Israel (4)  ·  Norway (4)  ·  Cyprus (3)

Top investigators

Elisabeth Kruse, PhD (16)  ·  Dorothy Hatsukami, Ph.D. (11)  ·  Caryn Lerman, PhD (8)  ·  Elliot Stein, Ph.D. (8)  ·  Dorothy Hatsukami, PhD (7)  ·  Jed E Rose, Ph.D. (7)  ·  James M Davis, MD (6)  ·  John R Hughes, MD (6)  ·  Timothy B Baker, PhD (6)  ·  Maria Varga, MD (5)  ·  Mehmet Sofuoglu, M.D.,Ph.D. (5)  ·  Robert A Schnoll, PhD (5)  ·  Shu-Hong Zhu, Ph.D. (5)  ·  Bernard Le Foll, MD, PhD (4)  ·  Caryn Lerman, Ph.D. (4)

Results publications

PMID 37142273, PMID 37230961, PMID 37335995, PMID 39868569, PMID 34611902, PMID 42560883, PMID 33605440, PMID 39101506, PMID 35420700, PMID 32628945, PMID 33079196, PMID 34242666, PMID 34255068, PMID 36208817, PMID 38236223, PMID 39240566, PMID 23485014, PMID 25192771, PMID 30946162, PMID 32534252, PMID 33300144, PMID 39799985, PMID 10165099, PMID 11206655, PMID 11282701, PMID 11298764, PMID 11420814, PMID 11493907, PMID 11738084, PMID 12525530, PMID 12589885, PMID 12745503, PMID 1370102, PMID 15796782, PMID 15961287, PMID 16499517, PMID 16960700, PMID 17141485, PMID 17295567, PMID 17587504, PMID 17624979, PMID 17632223, PMID 17654300, PMID 17712795, PMID 17763111, PMID 17943620, PMID 17984409, PMID 18072836, PMID 18096137, PMID 18374742

NIH funding

P50DA027840 (10), 2008 (7), U54DA036151 (7), P50DA009253 (5), P30CA016672 (4), P50AA015632 (4), P50CA143188 (4), P50DA019706 (4), R01DA017572 (4), U54DA036114 (4), K01DA019446 (3), P50DA009241 (3), P50DA013333 (3), P50DA036114 (3), R01HL109031 (3)